Subcutaneous Emphysema: Clinical Trials

3 trials for Subcutaneous Emphysema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Terminated 3

Follow Subcutaneous Emphysema: new trials by email Literature Review of Subcutaneous Emphysema trials Research Report on Subcutaneous Emphysema

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Environment Effect on Six-Minute Walk Test Performance
six-minute walk study indoors, six-minute walk study outdoors - Chronic Obstructive Pulmonary Disease, Alpha-1 Antitrypsin Deficiency
Not applicableTerminatedUniversity of Florida272015-10-012019-08-22
Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency
Implantation of intrabronchial valves (IBV) (Spiration IBV) - Hereditary Emphysema (Alpha 1-antitrypsin Deficiency)
Not applicableTerminatedHeidelberg University182011-05-012022-08-30
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Steen Solution™, Conventional Lung Transplant - Emphysema, Chronic Obstructive Pulmonary Disease (COPD)
Not applicableTerminatedUniversity of North Carolina, Chapel Hill112010-12-012018-07-13

Narrower conditions

alpha 1-Antitrypsin Deficiency (3)  ·  Emphysema (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Bronchiectasis (1)  ·  Cystic Fibrosis (1)  ·  Hypertension, Pulmonary (1)  ·  Pulmonary Fibrosis (1)  ·  Sarcoidosis (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Digestive System Diseases (3)  ·  Genetic Diseases, Inborn (3)  ·  Liver Diseases (3)  ·  Lung Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Respiratory Tract Diseases (3)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Lung Diseases, Obstructive (2)  ·  Bronchial Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Emphysema (1)

Sponsors

Heidelberg University (1)  ·  University of Florida (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (2)  ·  Germany (1)

Top investigators

Daniela Gompelmann, MD (1)  ·  Mark Brantly, MD (1)  ·  Thomas M. Egan, MD, MSc. (1)